This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignees: Oncotech, Inc., Onotech, Inc., Other. Active years: 1996-2008.
Location History:
- Fountain Valley, CA (US) (1996)
- Tustin, CA (US) (1998 - 2008)
Company Filing History:
Years Active: 1996-2008
Title: John P. Fruehauf: Innovator in Cancer Prognosis and Diagnosis
Introduction
John P. Fruehauf is a notable inventor based in Tustin, California. He has made significant contributions to the field of cancer research, particularly in the areas of prognosis and diagnosis. With a total of 11 patents, his work has the potential to impact clinical decisions and improve patient outcomes.
Latest Patents
Fruehauf's latest patents focus on innovative methods for cancer prognosis and diagnosis. One of his inventions provides methods for prognosis, diagnosis, staging, and disease progression in human cancer patients. This is related to the expression levels of a plurality of genes that are differentially expressed in chemotherapeutic drug-resistant and drug-sensitive tumor cells. Another patent offers methods that utilize immunohistochemical and genetic markers associated with poor cancer prognosis. These markers are particularly relevant to tumor invasiveness, metastasis, and the spread of cancer. His inventions also include a predictive index for assessing the prognosis of cancer patients regarding metastasis, recurrence, and relapse of neoplastic disease. These methods are crucial for making informed clinical decisions on cancer treatment, surveillance, and surgical intervention.
Career Highlights
Throughout his career, Fruehauf has worked with various companies, including Oncotech, Inc. and Onotech, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer diagnosis and treatment.
Collaborations
Fruehauf has collaborated with notable individuals in the field, including Eugene Mechetner and Ricardo J. Parker. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
John P. Fruehauf's contributions to cancer prognosis and diagnosis through his innovative patents highlight his dedication to improving patient care. His work continues to influence the medical community and offers hope for better cancer treatment strategies.